Page 17 | Certara

Publication

Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients

This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…

CertaraJanuary 22, 2026

On-Demand Webinar

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…

CertaraJanuary 22, 2026

Press Coverage

The data fragmentation problem holding drug discovery back

Explore how fragmented data across the drug discovery DMTA cycle impedes progress, and discover how…

CertaraJanuary 21, 2026

Blog

Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus

Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…

CertaraJanuary 16, 2026

Video

Check and Fix Structures – How to Marvin

Learn how to check and fix chemical structures from this episode of the How to…

CertaraJanuary 16, 2026

Video

Clean to Scaffold – How to Marvin

Learn how the clean to scaffold function works from this episode of the How to…

CertaraJanuary 16, 2026

Video

NMR Predictor – How to Marvin

Learn how to use the NMR predictor in Marvin from this episode of the How…

CertaraJanuary 16, 2026

Blog

The Rise of Biologics Discovery: From Small Molecules to Sequences

Biologics in drug discovery is becoming more important by the year. See where biologics discovery…

CertaraJanuary 15, 2026

Fact Sheet

Certara Solutions to Transform Drug Discovery and Development for Good

CertaraJanuary 15, 2026

Webinar

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

CertaraJanuary 14, 2026

Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

The data fragmentation problem holding drug discovery back

Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus

Check and Fix Structures – How to Marvin

Clean to Scaffold – How to Marvin

NMR Predictor – How to Marvin

The Rise of Biologics Discovery: From Small Molecules to Sequences

Certara Solutions to Transform Drug Discovery and Development for Good

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

Newsletter sign up

Quick links

Solutions

Contact